A Pharmacist-Led Education Program to Improve Adherence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation

NAEnrolling by invitationINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2031

Conditions
Atrial Fibrillation (AF)
Interventions
BEHAVIORAL

Pharmacist-led patient education

Trained pharnacists will provide information on: (1) the indication and the reason of DOAC prescription, (2) the name and the appearance of the DOAC agent, (3) the dose, frequency, time of administration, (4) the mechanism of action, (5) management of missed doses, (6) potential side effects and self-monitoring, and (7) perioperative management. An education leaflet about DOACs will also be provided to improve patients' understanding about the use of DOACs.

OTHER

Usual Care

Patients in the usual care group will receive only usual care, without pharmacists providing additional DOAC education materials.

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University

OTHER